USC Norris Comprehensive Cancer Center ( Site 0060) — Los Angeles, California

USC Norris Comprehensive Cancer Center ( Site 0060) is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

USC Norris Comprehensive Cancer Center ( Site 0060) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC), Kidney Cancer.

Sponsors: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USC Norris Comprehensive Cancer Center ( Site 0060)?

USC Norris Comprehensive Cancer Center ( Site 0060) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USC Norris Comprehensive Cancer Center ( Site 0060) conducted?

USC Norris Comprehensive Cancer Center ( Site 0060) has 1 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC), Kidney Cancer.

Is USC Norris Comprehensive Cancer Center ( Site 0060) accredited by Crixeo Health?

USC Norris Comprehensive Cancer Center ( Site 0060) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USC Norris Comprehensive Cancer Center ( Site 0060)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.